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Abstract
Objective: The objective of this study was to assess the correlation between antenatal cor-
ticosteroids and peri-intraventricular haemorrhage (PIVH) using transfontanelle ultraso-
nography, as well as to evaluate the risk factors for its incidence. Methods: We performed 
a retrospective cohort study using medical records of preterm newborns. The protocol for 
maternal corticoid administration for foetal lung maturation included dexamethasone 4 mg 
(intramuscular) 8/8 hours per 48 hours, with one cycle per week. The diagnosis of peri-
intraventricular haemorrhage was based on transfontanelle ultrasonography, using the Pap-
ile’s classification. The following risk factors for peri-intraventricular haemorrhage were 
assessed: birth weight, gestational age at delivery, type of delivery, newborn’s sex, surfactant 
administration, premature rupture of membranes and previous history of infection during 
the current pregnancy. The student’s t-test and chi-square test were used for statistical analy-
sis. Results: Our sample population included 184 preterm newborns. Transfontanelle ultra-
sonography revealed peri-intraventricular haemorrhage in 32 (74.4%) and periventricular 
leukomalacia in 11 (25.6%) newborns. Grade I haemorrhage was found in 20 (62.5%), grade 
II in five (15.6%), and grade III in seven (21.8%) newborns, as in accordance with Papile’s 
classification. Vaginal delivery (p = 0.010), birth weight <1500 g (p = 0.024), gestational 
age at delivery ≤32 weeks (p = 0.018), and previous history of infection during pregnancy 
(p = 0.013) were considered risk factors for peri-intraventricular haemorrhage in preterm 
newborns. Conclusion: Maternal corticoid administration for foetal lung maturation showed 
a protective effect against peri-intraventricular haemorrhage in preterm newborns. The risk 
factors for peri-intraventricular haemorrhage were determined. 
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Introduction
Prematurity is the main cause of neonatal morbid-
ity and mortality and is associated with severe, ma-
jor neurological conditions, such as intraventricular 
haemorrhage grades 3–4, periventricular leukoma-
lacia, and retinopathy of prematurity grades 3–4(1). 
Intraventricular haemorrhage (IVH) is the main 
complication in premature newborns and has an in-
cidence of 45% in premature neonates with a body 
weight of 500–750 g(2). IVH occurs in the periven-
tricular germinal matrix, which is the most fragile 
vascular brain region in premature infants. Further-
more, IVH may occur due to cerebral blood flow 
disturbance as well as platelet and coagulation dis-
orders. The risk factors for IVH include vaginal de-
livery, low Apgar score, severe respiratory distress 
syndrome, pneumothorax, hypoxia, hypercapnia, 
seizures, patent ductus arteriosus, thrombocytope-
nia, and infection(3,4). The majority of preterm new-
borns with IVH are asymptomatic and the diagnosis 
is based on cranial ultrasound screening. Severity 
classification is based on the location and the extent 
of IVH. The most commonly used classification is the 
one proposed by Papile(5).
Antenatal corticosteroid therapy reduces the rates of 
major neonatal morbidities, respiratory distress syn-
drome, IVH, and necrotizing enterocolitis as well as 
limits the need for respiratory support and intensive 
care admissions(6). Furthermore, antenatal cortico-
steroids reduce the risk of moderate cerebral palsy(7).
The objective of this study was to assess the correla-
tion between antenatal corticosteroid therapy and 
peri-IVH, as well as the risk factors associated with 
its incidence in a reference hospital in the northeast 
of Brazil. 
Materials and methods
We performed a retrospective cohort study using 
medical records of preterm newborns delivered in 
a University Hospital in the Northeast of Brazil, be-
tween January 2008 and December 2012. The study 
was approved by the Local Ethic Committee (ap-
proval no 001087/2013-60); no consent form was re-
quired as it was a retrospective study.
The inclusion criteria were as follows: preterm new-
borns from singleton pregnancies between 22w0d 
and 34w6d gestation; intact membranes or prema-
ture rupture of membranes. The exclusion criteria 
were as follows: newborns with chromosomal abnor-
malities or structural anomalies and maternal anten-
nal corticoid therapy for any reason other than to 
induce foetal lung maturation. The protocol for ma-
ternal corticoid administration for foetal lung matu-
ration included dexamethasone 4 mg (intramuscu-
lar) 8/8 h per 48 h, with one cycle per week. 
The diagnosis of peri-IVH was based on transfonta-
nelle ultrasonography performed using Tosbee appa-
ratus (Toshiba, Tokio, Japan) equipped with a micro 
convex (5 MHz) and liner probes (8 MHz). Ultrasound 
assessments were performed by an experienced ex-
aminer using the bregmatic fontanelle as an acoustic 
window in sagittal, axial, and coronal views to view 
the ventricular system and brain parenchyma. The 
first transfontanelle ultrasonography was performed 
between day 1 and day 10 after delivery. The second 
US scan was performed depending on the clinical 
status of newborns or, in the case of abnormalities 
detected in the first ultrasound examination, 15 days 
after the first US scan. If the first US scan was nor-
mal, the second one was performed after 30 days. 
The assessment of PIVH grade was based on the 
Papile’s classification(5): 1) haemorrhage restricted 
to the subependymal germinal matrix; 2) subependy-
mal and intraventricular haemorrhage, without ven-
tricular dilatation; 3) subependymal germinal matrix 
haemorrhage, intraventricular haemorrhage, and 
ventricular dilatation; and 4) parenchymal haemor-
rhage associated with intraventricular dilatation. We 
used first ultrasound findings for statistical analysis.
Data were transferred to Excel 2007 spreadsheet 
(Microsoft Corp., Redmond, WA, USA) and analysed 
with Stata version 11.0 (StataCorp LP, College Sta-
tion, TX, USA). The following risk factors for IVH 
were assessed: birth weight, gestational age at de-
livery, type of delivery, newborn’s sex, surfactant ad-
ministration, premature rupture of membranes, and 
previous history of infection during pregnancy (clin-
ical and/or laboratorial diagnosis). Birth weight was 
classified into three categories: A (birth weight <1000 
g), B (birth weight between 1000 and 1500 g), and C 
(birth weight >1500 g). Gestational age at delivery 
was classified into two categories: A (<32 w 0 d) and 
B (32w0–34w6d). For the descriptive analysis, we 
used simple frequencies for nominal variables, and 
the position (mean) and dispersion [standard devia-
tion (SD)] of numerical variables. We used the t-test 
to compare the mean between the groups and the 
chi-square test to compare the other qualitative vari-
ables. A p value (p) of < 0.05 was considered statisti-
cally significant. 
Results 
Our sample population consisted of 184 preterm 
newborns who were hospitalised in the Neonatal 
Intensive Care Unit of the University Hospital be-
tween January 2008 and December 2012. Ninety-
seven (53.1%) newborns were males and 87 (46.9%) 
were females. Transfontanellar ultrasonography re-
vealed abnormalities in 43 (23.3%) of the newborns; 
normal results were obtained in 141 (76.7%) new-
borns, 26 (60.5%) were females and 17 (39.5%) were 
males, with no statistical difference regarding sex 
(p = 0.97). 
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Transfontanelle ultrasonography revealed peri-IVH 
in 32 (74.4%) and periventricular leukomalacia in 11 
(25.6%) newborns. Grade I haemorrhage was found 
in 20 (62.5%), grade II in five (15.6%), and grade III 
in seven (21.8%) newborns, as in accordance with the 
Papile’s classification(5). Corticoids were administrated 
in 105 pregnant women (57.1%); of those 33 received 
one cycle, 23 received two cycles, 13 received three cy-
cles, and 23 received four cycles. Among the newborns 
whose mothers received corticoids during pregnancy, 
22 (20.9%) showed abnormalities in the transfontanelle 
ultrasonography and 83 (79.1%) were normal. In the 
case of mothers who did not receive corticoid therapy, 
21 (26.6%) newborns had peri-IVH and 58 (73.4%) were 
normal. There was a significant correlation between 
maternal corticoid administration and the presence of 
lesions on the transfontanelle ultrasound (p = 0.048). 
Regarding maternal corticoid administration and 
Papile’s classification, we observed an increase in the 
number of periventricular leukomalacia cases among 
pregnant women who did not use corticoids, however 
without statistical difference (p = 0.57) (Table 1). 
The mean gestational age (± SD) at delivery was 32 
± 2.1 weeks with 29 newborns <32 weeks and 14 ≥32 
weeks gestation, showing abnormalities in the trans-
fontanelle ultrasonography (p = 0.018). Regarding the 
birth weight, 27 (14.7%) newborns had a birth weight 
<1000 g, 78 (42.6%) had a birth weight of 1000–1500 
g, and 78 (42.6%) had a birth weight >1500 g. Re-
garding the relationship between birth weight and 
abnormal TF scan, we observed more cases of infants 
with a weight of 1000–1500 g with a statistical differ-
ence (p = 0.024). Regarding the type of delivery, there 
were 76 vaginal deliveries and 108 caesarean sec-
tions, with statistical difference between the type of 
delivery and abnormal TF scan (p = 0.01). Regarding 
the previous history of infection during pregnancy, 67 
(36.4%) mothers reported infections, 105 (57.1%) had 
no history of infection, and 12 (6.5%) had no infor-
mation on infections in medical records. There was 
a correlation between the history of infection and TF 
scan abnormalities (p = 0.013) (Table 2). 
Discussion
In our study, 184 (17.4%) preterm newborns had 
peri-IVH, and this rate was consistent with the find-
ings of Farange and Assis, who observed PIVH in-
cidence rate of 15% in a University Hospital in the 
southeast of Brazil(8). Periventricular haemorrhage 
was more frequent (62.5%), and 37.49% of the most 
severe cases corresponded with IVH. Hence, the ma-
jority of neurological vascular lesions were classi-
fied as Papile grade I, which is consistent with Man-
cini et al.(9) who found incidences of up to 70% for 
Papile grade I. 
Variable Papile I n (%)
Papile II
n (%)
Papile III
n (%)
PVL
n (%) P Value
Maternal corticoid therapy 0,57
Present 12 (54.5) 1 (4.5) 3 (13.6) 6 (27.2)
Absent 8 (38.0) 4 (19.1) 4 (19.1) 5 (23.8)
PVL – periventricular leukomalacia
Tab. 1.  Correlation between maternal corticoid administration and the presence of periventricular leukomalacia graded according to the 
Papile scoring system, as revealed by transfontanelle ultrasonography
Variable
TFUS 
Normal
n (%)
TFUS  
Abnormal
n (%)
P Value
Gestational age at 
delivery    0.018
≤32 weeks 65 (69.5) 29 (30.5)  
32–34 weeks 75 (84.3) 14 (15.7)  
Birth weight   0.024
≤1000 g 16 (59.3) 11 (40.7)  
1000–1500 g 59 (75.6) 19 (24.4)
≥1500 g 66 (84.2) 12 (15.3)  
Type of delivery   0.010
Vaginal 51 (67.1) 25 (32.9)  
Caesarean 90 (83.4) 18 (16.7)  
Surfactant 
administration     0.374
Yes 73 (73.0) 27 (27.0)  
No 66 (81.5) 15 (18.5)  
No information 2 (66.7) 1 (33.3)  
Premature rupture 
of membranes   0.162
Tak 34 (69.4) 15 (30.6)  
Nie 107 (79.3) 28 (20.7)  
Previous history  
of infection   0.013
Yes 53 (79.1) 14 (20.9)  
No 83 (79.0) 22 (20.9)  
No information 5 (41.7) 7 (58.3)  
TFUS – transfontanelle ultrasonography
Tab. 2.  Correlation between abnormalities in transfontanelle ultraso-
nography and factors associated with preterm birth
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In the present study, maternal corticoid administra-
tion to accelerate foetal lung maturation showed 
a protective effect against PIVH in preterm new-
borns, which is consistent with previous studies(10,11). 
More severe cases occurred in preterm newborns 
whose mothers did not receive antenatal corticoids; 
however, without statistical difference. In our study, 
we used weekly cycles of maternal corticoid therapy 
for foetal lung maturation as this was the current 
protocol at the time of our study (January 2008 and 
December 2012). In the beginning of 2013, the pro-
tocol was changed and included only one cycle of 
four 6mg dexamethasone doses (intramuscular) at 
12-hour intervals. The choice of dexamethasone is 
a consequence of a systematic review which showed 
lower rates of IVH compared to betamethasone in 
pregnant women with risk of preterm birth(12). 
There was a correlation between peri-IVH and the 
newborn sex, which was observed in previous stud-
ies(13). In our study, there was a statistically signifi-
cant correlation between the female sex (60.5%) and 
peri-IVH, as opposed to Sarker et al.(14) who observed 
higher incidence among males. 
In our study, 57.4% of all preterm newborns had 
a weight <1500 g and showed a direct correlation 
with PIVH. Mancini et al.(9) observed a PIVH in-
cidence rate of 29.8% in preterm newborns with 
a weight <1500 g. We also observed a significant 
correlation between PIVH and gestational age at de-
livery ≤32 weeks gestation. Mancini et al.(9) observed 
the gestational age of 30 weeks as the cut-off with 
a PIVH rate of 47.3%. 
We observed a significant correlation between vagi-
nal delivery and PIVH, proving the protective effect 
of caesarean section in preterm foetuses mainly at 
≤32 weeks gestation. According to O’Shea et al.(15), 
the most import measure to prevent PIVH was not 
the type of delivery, but avoiding the second stage of 
labour. Similarly, Gawade et al.(16) observed that the 
risk of mild IVH was increased in preterm newborns 
exposed to the second stage of labour compared to 
elective caesarean section, however without statisti-
cal significance relative to severe IVH. However, new 
randomized controlled trials are necessary to prove 
the protective effect of caesarean section on IVH in 
preterm newborns. Furthermore, we observed a sig-
nificant correlation between previous history of in-
fection during pregnancy and PIVH, which was also 
observed by Harding et al.(17)
Our study was limited by a relatively small sample, 
which included 57.4% of preterm newborns with 
a weight <1500 g. More severe IVH cases occurred 
in preterm newborns who did not receive antenatal 
corticosteroids; however, without statistical signifi-
cance. We believe that a larger sample size mainly 
including preterm newborns <32 weeks gestation 
could prove the real benefit of corticosteroids. An-
other limitation of this study was related to the 
weekly cycles of maternal corticoid therapy, which 
did not allow to verify whether only one cycle en-
sured a protective effect against PIVH in preterm 
newborns.
In conclusion, maternal corticoid administration to 
induce foetal lung maturation showed a protective 
effect against peri-IVH in preterm newborns. Vagi-
nal delivery, birth weight <1500 g, gestational age at 
delivery ≤32 weeks, and previous history of infection 
during pregnancy were considered risk factors for 
peri-IVH in preterm newborns.
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